Potential implications of SARS-CoV-2 epidemic in Africa: where are we going from now?

被引：12

作者：

Torti, Carlo ^{[1
]}

Mazzitelli, Maria ^{[1
]}

Trecarichi, Enrico Maria ^{[1
]}

Darius, Owachi ^{[2
]}

机构：

[1] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Infect & Trop Dis Unit, I-88100 Catanzaro, Italy

[2] Kiruddu Natl Referral Hosp, Dept Infect Dis, Kampala, Uganda

来源：

BMC INFECTIOUS DISEASES | 2020年 / 20卷 / 01期

关键词：

Coronavirus; COVID-19; SARS-CoV-2; Africa; Low-income countries; MEDICINAL-PLANTS;

D O I：

10.1186/s12879-020-05147-8

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

The SARS-CoV-2, which emerged from East Asia in December 2019, has rapidly evolved into a global pandemic infecting close to 7 million people. The current uncertainties regarding its impact on Africa calls for critical monitoring of the evolution of the pandemic and correlation of factors that influence the burden of the disease. We herein discuss possible implications of SARS-CoV-2 on the African continent.

引用

页数：6

共 50 条

[1] Potential implications of SARS-CoV-2 epidemic in Africa: where are we going from now?
Carlo Torti
Maria Mazzitelli
Enrico Maria Trecarichi
Owachi Darius
BMC Infectious Diseases, 20
[2] Azithromycin and SARS-CoV-2 infection: Where we are now and where we are going
Parra-Lara, Luis Gabriel
Jose Martinez-Arboleda, Juan
Rosso, Fernando
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2020, 22 : 680 - 684
[3] SARS-CoV-2 Vaccines: Where Are We Now?
Flanagan, Katie L.
MacIntyre, C. Raina
McIntyre, Peter B.
Nelson, Michael R.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (10) : 3535 - 3543
[4] SARS-CoV-2 Antibody Testing: Where Are We Now?
Smerczak, Elizabeth
LABORATORY MEDICINE, 2022, 53 (02) : E19 - E29
[5] Structural Characterization of SARS-CoV-2: Where We Are, and Where We Need to Be
Mariano, Giuseppina
Farthing, Rebecca J.
Lale-Farjat, Shamar L. M.
Bergeron, Julien R. C.
FRONTIERS IN MOLECULAR BIOSCIENCES, 2020, 7
[6] SARS-CoV-2 and Parkinson's Disease: A Review of Where We Are Now
Boura, Iro
Qamar, Mubasher A.
Daddoveri, Francesco
Leta, Valentina
Poplawska-Domaszewicz, Karolina
Falup-Pecurariu, Cristian
Chaudhuri, K. Ray
BIOMEDICINES, 2023, 11 (09)
[7] SARS-CoV-2 vaccine development: where are we?
Galdiero, M.
Folliero, V
Zannella, C.
De Filippis, A.
Mali, A.
Rinaldi, L.
Franci, G.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (06) : 2752 - 2784
[8] SARS-CoV-2 vaccines, where do we stand?
Fischer, Alain
COMPTES RENDUS BIOLOGIES, 2021, 344 (01) : 43 - 55
[9] Sequence similarity of SARS-CoV-2 and humans: Implications for SARS-CoV-2 detection
Li, Heng
Hong, Xiaoping
Ding, Liping
Meng, Shuhui
Liao, Rui
Jiang, Zhenyou
Liu, Dongzhou
FRONTIERS IN GENETICS, 2022, 13
[10] The impact of the SARS-CoV-2 epidemic on mortality in South Africa in 2020
Dorrington, R. E.
Laubscher, R.
Nannan, N.
Bradshaw, D.
SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2022, 112 (01): : 24 - 26

← 1 2 3 4 5 →